Home / Inspections / 1255905

FDA Inspection 1255905 — Zhejiang Huahai Pharmaceutical

Zhejiang Huahai Pharmaceutical — FEI 3003885745

The FDA completed an inspection of Zhejiang Huahai Pharmaceutical on November 20, 2024 in Linhai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 20, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Linhai (China)

Facility

Other inspections at this facility

  • 1150702 (NAI Thu Jul 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1062283 (OAI Fri Aug 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1012805 (VAI Fri May 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 886530 (NAI Fri May 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 712157 (NAI Wed Sep 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources